Information  X 
Enter a valid email address

Genus (GNS)

  Print      Mail a friend       Annual reports

Wednesday 21 November, 2018

Genus

Director Declaration

RNS Number : 9084H
Genus PLC
21 November 2018
 

21 November 2018

Genus plc

Director Declaration

Genus plc (LSE: GNS) today announces that Lykele van der Broek, Non-Executive Director, has been appointed as a Non-Executive Director and Chairman of the Supervisory Board of Aspen Oss B.V., a manufacturer of active pharmaceutical ingredients in the human healthcare sector, which is a wholly owned subsidiary of Aspen Pharmacare Holdings Ltd listed on the Johannesburg Stock Exchange, with effect from 21 November 2018.

This announcement is being made pursuant to 9.6.14 of the Listing Rules.

 

For further information please contact:

Genus:

Dan Hartley, Group General Counsel & Company Secretary                         Tel: +44 (0)1256 347100

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RDNBBLFLVFFEFBX

a d v e r t i s e m e n t